Live Breaking News & Updates on Daniel Carlson Tailwinds Research Analyst

Stay updated with breaking news from Daniel carlson tailwinds research analyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TFF Pharmaceuticals, Inc. (TFFP) Q1 2022 Earnings Call Transcript

TFFP earnings call for the period ending March 31, 2022. ....

United States , Kirk Coleman , Ted Ross , Ted Ketterer , Mayank Mamtani , Leo Saraceno Waushacum , Dale Christensen , Bill Williams , Richard Deutsch , Anthony Plogesma , Zhib Riley , Albert Einstein , Corey Davis , Daniel Carlson , Leo Saraceno , Jonathan Aschoff , Safety Management Committee , Daniel Carlson Tailwinds Research Analyst , National Securities , Tk Associates , Tff Pharmaceuticals Inc , Pharmaceuticals Inc , Clinical Development , Geneva Foundation , York Stock Exchange , Union Therapeutics ,

INmune Bio, Inc. (INMB) Q4 2020 Earnings Call Transcript

Operator
Greetings, and welcome to the INmune Bio fourth-quarter 2020 earnings conference call. [Operator instructions] As a reminder, this conference call is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is my pleasure to introduce Mr.
David Moss, co-founder and CFO of INmune Bio. David, the floor is yours.
David Moss
Co-Founder and Chief Executive Officer
Thank you, Rob, and good afternoon, everybody. We thank you for joining us for the call for INmune Bio s fourth-quarter 2020 financial results. With me on the call is Dr. RJ Tesi, CEO and co-founder of INmune Bio, who will provide a business update. ....

Andy Miller , David Moss , Michael Irwin , Inmune Bio , Janet Woodcock , Biosciences Tmtcalibrator , Tom Shrader , Swayampakula Ramakanth , Jen Felger , Brett Conrad , Michael Irwin Univest , Daniel Carlson , Jonathan Aschoff , David Moss Co , Daniel Carlson Tailwinds Research Analyst , Inmune Bio Inc , Emory University , Rj Tesi Co , National Health Service , Tailwinds Research , Chief Executive , Private Securities Litigation Reform Act , Chief Financial , Proteome Biosciences , Professor Andy Miller , Associate Professor Jen Felger ,